Using GLP1 receptor agonists to treat cardiac patients with diabetes

Описание к видео Using GLP1 receptor agonists to treat cardiac patients with diabetes

At our 2018 symposium, "Management of Type 2 Diabetes in Patients with CVD: Focus on Heart Failure," Sunnybrook's Dr. Julie Lovshin explores GLP1 receptor agonist therapy in the setting of type 2 diabetes.

Комментарии

Информация по комментариям в разработке